Status:
COMPLETED
Oropharyngeal Dysphagia in Patients With COVID-19
Lead Sponsor:
Hospital de Mataró
Collaborating Sponsors:
Centro Investigación Biomédica en Red de Enfermedades Hepáticas Digestivas
Conditions:
Oropharyngeal Dysphagia
COVID-19
Eligibility:
All Genders
Brief Summary
Background: Oropharyngeal dysphagia (OD) is a common complication in/post ICU patients that have been with intubation/mechanical ventilation or with tracheotomies or NG tubes, in patients with acute r...
Detailed Description
Design: 1) prospective study in SARS-CoV-2 infected patients admitted to the CSdM more than 48h with 2 follow-up points at 3/6 months after discharge. 2\) comparative study between the 3 first waves ...
Eligibility Criteria
Inclusion
- Infected patients (COVID-19 + by PCR or according to physician's criteria in the medical report of the patient at discharge) admitted to the CSdM more than 48 h.
- Patients able to be explored regarding OD and nutritional status according to their physician's criteria (fully awake patients in a stable respiratory situation and optimal PaO2/FiO2).
Exclusion
- Uncontrolled risk of infection for healthcare professionals (HCP) (according to the safety considerations stated below).
Key Trial Info
Start Date :
April 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
605 Patients enrolled
Trial Details
Trial ID
NCT04346212
Start Date
April 14 2020
End Date
September 30 2021
Last Update
July 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Consorci Sanitari del Maresme (Hospital de Mataró)
Mataró, Barcelona, Spain, 08301